On the other hand, certain polymorphisms in the IL-6 receptor gene that attenuate IL-6 signalling have been shown to be protective against disease progression, resulting in a lower risk of hospitalisation for COVID-19 (24). This evidence concerns the gene IL6 and COVID-19.